Results 251 to 259 of about 93,221 (259)

Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

Lancet Oncology, The, 2017
Rajen Mody, Arlene Naranjo, Alice L Yu
exaly  

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

JAMA - Journal of the American Medical Association, 2017
Roger Stupp, Andrew Ariye Kanner, Ahmed Idbaih   +2 more
exaly  

Temozolomide

Reactions Weekly, 2008
openaire   +1 more source

Temozolomide

Reactions Weekly, 2014
openaire   +1 more source

Temozolomide improves outcomes

Nature Reviews Clinical Oncology, 2017
exaly  

Lomustine–temozolomide combination efficacious in newly diagnosed glioblastoma

Nature Reviews Clinical Oncology, 2019
exaly  

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients

Annals of Oncology, 2009
exaly  

Current and future developments in the use of temozolomide for the treatment of brain tumours

Lancet Oncology, The, 2001
exaly  

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models

Cancer Cell
exaly